Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Consumer Discretionary Select Sector SPDR Fund (XLY) Price & Performance

Neurocrine Biosciences IncTrade
Consumer Discretionary Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Consumer Discretionary Select Sector SPDR Fund trades at $114.85. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.

NBIXXLY
Market Cap
$17.40B
Sector
Health
52-Week High
$180.55$124.52
52-Week Low
$123.10$105.64
Enterprise Value
$16.49B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Consumer Discretionary Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.

Read more on XLY